Solitary Brain Metastasis As First Manifestation of Small-Cell Parotid Gland Carcinoma With High Sensitivity to Temozolomide Therapy on Basis of Tumor O6-Methylguanine-DNA-Methyltransferase Expression

被引：0
|
作者：
Lolli, Ivan [1 ]
Morra, Isabella [2 ]
Cimmino, Antonella [3 ]
Trevisan, Elisa [4 ]
Ruda, Roberta [4 ]
Piombino, Michele [3 ]
Campanella, Giovanna [1 ]
Tos, Anna Gillio [5 ]
De Marco, Laura [5 ]
Trevisan, Morena [5 ]
Fiano, Valentina [5 ]
Soffietti, Riccardo [4 ]
机构：
[1] Ist Ricovero & Cura Carattere Sci Saverio Bellis, Bari, Italy
[2] Presidi Osped Osped Infantile Regina Margherita S, Turin, Italy
[3] Azienda Osped Univ Policlin, Bari, Italy
[4] Univ Turin, Turin, Italy
[5] Univ Turin, Ctr Expt Res & Med Studies, Turin, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 23期
关键词：
MGMT;
D O I：
10.1200/JCO.2012.47.5590
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E394 / E397
页数：4
相关论文
共 7 条
  • [1] O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients
    Spiegl-Kreinecker, Sabine
    Pirker, Christine
    Filipits, Martin
    Loetsch, Daniela
    Buchroithner, Johanna
    Pichler, Josef
    Silye, Rene
    Weis, Serge
    Micksche, Michael
    Fischer, Johannes
    Berger, Walter
    NEURO-ONCOLOGY, 2010, 12 (01) : 28 - 36
  • [2] O6-METHYLGUANINE DNA METHYLTRANSFERASE (MGMT) PROMOTER METHYLATION IN PRIMITIVE NEUROECTODERMAL BRAIN TUMOR (PNET) CORRELATES WITH MGMT RNA EXPRESSION AND SENSITIVITY OF PNET CELLS TO TEMOZOLOMIDE
    von Bueren, Andre
    Faoro, Denis
    Shalaby, Tarek
    Huerlimann, Marie-Louise
    Arnold, Luzia
    Gerber, Nicolas
    Haybaeck, Johannes
    Mittelbronn, Michel
    Hegi, Monika
    Rutkowski, Stefan
    Grotzer, Michael
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 825 - 825
  • [3] Role of O-6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin
    Bobola, MS
    Tseng, SH
    Blank, A
    Berger, MS
    Silber, JR
    CLINICAL CANCER RESEARCH, 1996, 2 (04) : 735 - 741
  • [4] O6-Methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma
    Watanabe, Reiko
    Nakasu, Yoko
    Tashiro, Hiroshi
    Mitsuya, Koichi
    Ito, Ichiro
    Nakasu, Satoshi
    Nakajima, Takashi
    BRAIN TUMOR PATHOLOGY, 2011, 28 (02) : 127 - 135
  • [5] O6-Methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma
    Reiko Watanabe
    Yoko Nakasu
    Hiroshi Tashiro
    Koichi Mitsuya
    Ichiro Ito
    Satoshi Nakasu
    Takashi Nakajima
    Brain Tumor Pathology, 2011, 28 : 127 - 135
  • [6] Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression
    Rathkey, Daniel
    Khanal, Manakamana
    Murai, Junko
    Zhang, Jingli
    Sengupta, Manjistha
    Jiang, Qun
    Morrow, Betsy
    Evans, Christine N.
    Chari, Raj
    Fetsch, Patricia
    Chung, Hye-Jung
    Xi, Liqiang
    Roth, Mark
    Filie, Armando
    Raffeld, Mark
    Thomas, Anish
    Pommier, Yves
    Hassan, Raffit
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (05) : 843 - 859
  • [7] Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O6-methylguanine DNA methyltransferase expression
    Brandwein, Joseph M.
    Kassis, Jeannine
    Leber, Brian
    Hogge, Donna
    Howson-Jan, Kang
    Minden, Mark D.
    Galarneau, Andre
    Pouliot, Jean-Francois
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (05) : 664 - 670
1